“A nursing home my pharmacy services has two patients who have chronic, asymptomatic hepatitis C infection. For one patient, there is little issue. There is no symptoms as discussed, and there is very little risk of transmission. For another patient, this is not the case. While asymptomatic, they also have diabetes, and as a result there is a significant amount of handling of biological hazard for the staff, plus a small but real risk of needle-stick injury. In both cases, there is very little benefit to the patient in undergoing eradication therapy. The question remains though, should the second patient be treated?”
- Not in Australia!
- β-Blockers, heart disease and COPD
- New brand premiums
- Nicotine patches and Quitline.
- Asthma and Vit D
- E Cigarettes
Click here to visit the AJP Discussion Forum.
Haven’t registered yet? Click here.